ANDA 62895, held by Chartwell Rx. Cyclacillin.
As of Nov 13, 2026, ANDA 62895 (Cyclacillin), held by Chartwell Rx, was first approved by FDA on May 4, 1988, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 4, 1988 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Cyclacillin250MG · tablet;oral | Cyclacillin | Discontinued |
| Cyclacillin500MG · tablet;oral | Cyclacillin | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
